Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$4.2 - $6.18 $763,568 - $1.12 Million
181,802 Added 1344.79%
195,321 $832,000
Q1 2024

May 03, 2024

BUY
$6.08 - $8.28 $82,195 - $111,937
13,519 New
13,519 $83,000
Q2 2023

Aug 14, 2023

BUY
$4.88 - $7.39 $202,861 - $307,202
41,570 New
41,570 $208,000
Q3 2021

Nov 12, 2021

SELL
$9.73 - $13.38 $103,498 - $142,323
-10,637 Closed
0 $0
Q2 2021

Aug 05, 2021

SELL
$9.02 - $11.68 $120,759 - $156,371
-13,388 Reduced 55.73%
10,637 $108,000
Q1 2021

May 10, 2021

SELL
$9.53 - $15.42 $1,867 - $3,022
-196 Reduced 0.81%
24,025 $280,000
Q4 2020

Feb 03, 2021

BUY
$10.35 - $15.94 $250,687 - $386,082
24,221 New
24,221 $256,000
Q2 2020

Aug 11, 2020

SELL
$9.71 - $17.87 $280,570 - $516,353
-28,895 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$5.57 - $10.76 $160,945 - $310,910
28,895 New
28,895 $311,000
Q4 2019

Feb 12, 2020

SELL
$7.21 - $8.89 $149,766 - $184,663
-20,772 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$6.57 - $9.46 $4,001 - $5,761
-609 Reduced 2.85%
20,772 $155,000
Q2 2019

Aug 06, 2019

BUY
$8.17 - $11.07 $174,682 - $236,687
21,381 New
21,381 $198,000
Q4 2018

Feb 12, 2019

SELL
$10.53 - $15.54 $195,078 - $287,894
-18,526 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$15.25 - $17.72 $282,521 - $328,280
18,526 New
18,526 $286,000
Q1 2018

May 11, 2018

SELL
$16.77 - $22.04 $578,531 - $760,335
-34,498 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$13.44 - $22.81 $463,653 - $786,899
34,498
34,498 $651,000

Others Institutions Holding OSUR

About ORASURE TECHNOLOGIES INC


  • Ticker OSUR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 72,619,104
  • Market Cap $283M
  • Description
  • OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...
More about OSUR
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.